In the United States, patent owners can seek several different
types of remedies when considering a patent infringement
litigation. Some remedies, like injunctions or orders barring
imports, are more prevalent in particular industries. Some, like
pharmaceutical and biosimilar exclusivity, are industry-specific.
Most patent owners suing for infringement in US courts seek
monetary damages.
For most patent owners, the amount of recoverable damages for
patent infringement is a primary driver when deciding when to
bring, defend, or settle patent litigation. The potential damages
from litigation also drives (offensive and defensive) licensing
decisions and freedom-to-operate analyses (when balancing
design-around costs). US patent law guarantees a prevailing patent
owner at least "a reasonable royalty."1
However, determining the potential damages (both before and during
litigation) can prove complex, particularly for the multi-component
products common in today's global